US Patent 7968286 Settings for recombinant adenoviral-based vaccines
Patent 7968286 was granted and assigned to Crucell on June, 2011 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
January 12, 2011
Date of Patent
June 28, 2011
Patent Application Number
12930661
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 7968286 Settings for recombinant adenoviral-based vaccines
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
